Global Iron Deficiency Injectable Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Iron Deficiency Injectable market size was valued at US$ 3494 million in 2024 and is forecast to a readjusted size of USD 5956 million by 2031 with a CAGR of 8.0% during review period.
Iron deficiency injectables are the drugs which are prescribed for treating iron deficiency and delivered by intravenous (IV) infusion in the body. These IV drugs offer numerous benefits over oral medications by guaranteeing faster absorption of the infused supplements. Iron-deficiency anaemia is a disorder in which the blood does not have enough healthy red blood cells due to the deficiency of iron. For treating these patiets, these injectables are used. It is used only for the treatment of patients who cannot be treated appropriately with oral iron supplements.
Currently, increasing geriatric population, increasing prevalence of chronic diseases such as cancer, chronic kidney disease, and rising number of patients undergoing dialysis are driving the iron deficiency injectables market. High prevalence of iron deficiency anemia due to polycystic ovary syndrome (PCOS) and rising incidence of hemodilution in pregnant women are also increasing the demand for iron deficiency injections.
This report is a detailed and comprehensive analysis for global Iron Deficiency Injectable market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Iron Deficiency Injectable market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Iron Deficiency Injectable market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Iron Deficiency Injectable market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Iron Deficiency Injectable market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Iron Deficiency Injectable
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Iron Deficiency Injectable market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie Inc, Covis Pharma GmbH, DAIICHI SANKYO COMPANY, LIMITED, Fresenius Kabi AG, Vifor Pharma Management Ltd, PHARMACOSMOS A/S, Shield Therapeutics plc, American Regent, Inc, Rockwell Medical, Inc, Apotex Inc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Iron Deficiency Injectable market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Iron Dextran
Iron Sucrose
Ferric Carboxymaltose
Market segment by Application
Chronic Kidney Disease
Inflammatory Bowel Disease
Cancer
Other
Major players covered
AbbVie Inc
Covis Pharma GmbH
DAIICHI SANKYO COMPANY, LIMITED
Fresenius Kabi AG
Vifor Pharma Management Ltd
PHARMACOSMOS A/S
Shield Therapeutics plc
American Regent, Inc
Rockwell Medical, Inc
Apotex Inc
Bayer AG
Akebia Therapeutics, Inc
GSK plc
Novartis AG
Aetna Inc
Pfizer Inc
Systacare Remedies
BSA Pharma Inc
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Iron Deficiency Injectable product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Iron Deficiency Injectable, with price, sales quantity, revenue, and global market share of Iron Deficiency Injectable from 2020 to 2025.
Chapter 3, the Iron Deficiency Injectable competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Iron Deficiency Injectable breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Iron Deficiency Injectable market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Iron Deficiency Injectable.
Chapter 14 and 15, to describe Iron Deficiency Injectable sales channel, distributors, customers, research findings and conclusion.
Iron deficiency injectables are the drugs which are prescribed for treating iron deficiency and delivered by intravenous (IV) infusion in the body. These IV drugs offer numerous benefits over oral medications by guaranteeing faster absorption of the infused supplements. Iron-deficiency anaemia is a disorder in which the blood does not have enough healthy red blood cells due to the deficiency of iron. For treating these patiets, these injectables are used. It is used only for the treatment of patients who cannot be treated appropriately with oral iron supplements.
Currently, increasing geriatric population, increasing prevalence of chronic diseases such as cancer, chronic kidney disease, and rising number of patients undergoing dialysis are driving the iron deficiency injectables market. High prevalence of iron deficiency anemia due to polycystic ovary syndrome (PCOS) and rising incidence of hemodilution in pregnant women are also increasing the demand for iron deficiency injections.
This report is a detailed and comprehensive analysis for global Iron Deficiency Injectable market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Iron Deficiency Injectable market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Iron Deficiency Injectable market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Iron Deficiency Injectable market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Iron Deficiency Injectable market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Iron Deficiency Injectable
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Iron Deficiency Injectable market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie Inc, Covis Pharma GmbH, DAIICHI SANKYO COMPANY, LIMITED, Fresenius Kabi AG, Vifor Pharma Management Ltd, PHARMACOSMOS A/S, Shield Therapeutics plc, American Regent, Inc, Rockwell Medical, Inc, Apotex Inc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Iron Deficiency Injectable market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Iron Dextran
Iron Sucrose
Ferric Carboxymaltose
Market segment by Application
Chronic Kidney Disease
Inflammatory Bowel Disease
Cancer
Other
Major players covered
AbbVie Inc
Covis Pharma GmbH
DAIICHI SANKYO COMPANY, LIMITED
Fresenius Kabi AG
Vifor Pharma Management Ltd
PHARMACOSMOS A/S
Shield Therapeutics plc
American Regent, Inc
Rockwell Medical, Inc
Apotex Inc
Bayer AG
Akebia Therapeutics, Inc
GSK plc
Novartis AG
Aetna Inc
Pfizer Inc
Systacare Remedies
BSA Pharma Inc
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Iron Deficiency Injectable product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Iron Deficiency Injectable, with price, sales quantity, revenue, and global market share of Iron Deficiency Injectable from 2020 to 2025.
Chapter 3, the Iron Deficiency Injectable competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Iron Deficiency Injectable breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Iron Deficiency Injectable market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Iron Deficiency Injectable.
Chapter 14 and 15, to describe Iron Deficiency Injectable sales channel, distributors, customers, research findings and conclusion.
Table of Contents
135 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: Iron Deficiency Injectable by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
